{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T07:07:07Z","timestamp":1784358427007,"version":"3.55.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1124\/dmd.116.072041","type":"journal-article","created":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T02:13:42Z","timestamp":1469499222000},"page":"1603-1607","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Bioactivation of Trimethoprim to Protein-Reactive Metabolites in Human Liver Microsomes"],"prefix":"10.1016","volume":"44","author":[{"given":"Jennifer L","family":"Goldman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yakov M","family":"Koen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James S","family":"Leeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P","family":"Hanzlik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.116.072041_bib1","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/BF01640549","article-title":"Comparison of sulfamethoxazole alone and combined with trimethoprim in urinary tract infections","volume":"7","author":"Bergan","year":"1979","journal-title":"Infection"},{"key":"10.1124\/dmd.116.072041_bib2","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00204-015-1456-2","article-title":"Drug-induced liver injury: an overview over the most critical compounds","volume":"89","author":"Bj\u00f6rnsson","year":"2015","journal-title":"Arch Toxicol"},{"issue":"Suppl 7","key":"10.1124\/dmd.116.072041_bib3","doi-asserted-by":"crossref","first-page":"S388","DOI":"10.1007\/BF01715834","article-title":"Double-blind comparative study of ofloxacin (Hoe 280) and trimethoprim-sulfamethoxazole in the treatment of patients with acute exacerbations of chronic bronchitis and chronic obstructive lung disease","volume":"19","author":"Boye","year":"1991","journal-title":"Infection"},{"key":"10.1124\/dmd.116.072041_bib4","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1124\/mol.107.043273","article-title":"Covalent binding of the nitroso metabolite of sulfamethoxazole is important in induction of drug-specific T-cell responses in vivo","volume":"73","author":"Cheng","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.116.072041_bib5","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/S0022-3565(24)36874-0","article-title":"Patients with delayed-onset sulfonamide hypersensitivity reactions have antibodies recognizing endoplasmic reticulum luminal proteins","volume":"282","author":"Cribb","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.116.072041_bib6","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/clpt.1992.57","article-title":"Sulfamethoxazole is metabolized to the hydroxylamine in humans","volume":"51","author":"Cribb","year":"1992","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.116.072041_bib7","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1021\/tx8002593","article-title":"Trimethoprim: novel reactive intermediates and bioactivation pathways by cytochrome p450s","volume":"21","author":"Damsten","year":"2008","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.116.072041_bib8","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/0006-2952(91)90627-H","article-title":"Hydroxylation and formation of electrophilic metabolites of tienilic acid and its isomer by human liver microsomes. Catalysis by a cytochrome P450 IIC different from that responsible for mephenytoin hydroxylation","volume":"41","author":"Dansette","year":"1991","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.116.072041_bib9","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1124\/dmd.115.065193","article-title":"In vitro hepatic oxidative biotransformation of trimethoprim","volume":"43","author":"Goldman","year":"2015","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.116.072041_bib10","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1053\/jhep.2000.9034","article-title":"Cytochrome P450-generated reactive metabolites cause mitochondrial permeability transition, caspase activation, and apoptosis in rat hepatocytes","volume":"32","author":"Haouzi","year":"2000","journal-title":"Hepatology"},{"key":"10.1124\/dmd.116.072041_bib11","first-page":"9","article-title":"A comparison of trimethorprim-sulfamethoxazole with sulfamethoxazole alone in infections localized to the kidneys","volume":"112","author":"Harding","year":"1975","journal-title":"Can Med Assoc J"},{"key":"10.1124\/dmd.116.072041_bib12","first-page":"251","article-title":"Severe trimethoprim induced neutropenia and thrombocytopenia","volume":"106","author":"Hawkins","year":"1993","journal-title":"N Z Med J"},{"key":"10.1124\/dmd.116.072041_bib13","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1021\/jm00287a029","article-title":"An improved synthesis of diaveridine, trimethoprim, and closely related 2,4-diaminopyrimidines","volume":"14","author":"Hoffer","year":"1971","journal-title":"J Med Chem"},{"key":"10.1124\/dmd.116.072041_bib14","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/toxsci\/65.2.166","article-title":"Mechanisms of hepatotoxicity","volume":"65","author":"Jaeschke","year":"2002","journal-title":"Toxicol Sci"},{"key":"10.1124\/dmd.116.072041_bib15","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1021\/tx300103j","article-title":"Identification of protein targets of reactive metabolites of tienilic acid in human hepatocytes","volume":"25","author":"Koen","year":"2012","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.116.072041_bib16","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0022-3565(24)35100-6","article-title":"Metabolism of trimethoprim to a reactive iminoquinone methide by activated human neutrophils and hepatic microsomes","volume":"291","author":"Lai","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.116.072041_bib17","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1124\/jpet.109.160804","article-title":"Genetic predictors of interindividual variability in hepatic CYP3A4 expression","volume":"332","author":"Lamba","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.116.072041_bib18","doi-asserted-by":"crossref","first-page":"778.e1","DOI":"10.1016\/j.amjmed.2009.01.034","article-title":"Self-reported antibiotic allergy incidence and prevalence: age and sex effects","volume":"122","author":"Macy","year":"2009","journal-title":"Am J Med"},{"key":"10.1124\/dmd.116.072041_bib19","first-page":"345","article-title":"Fatal adverse drug reaction to trimethoprim","volume":"34","author":"Mortimer","year":"2005","journal-title":"Aust Fam Physician"},{"key":"10.1124\/dmd.116.072041_bib20","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1124\/mol.62.3.628","article-title":"Covalent binding of the nitroso metabolite of sulfamethoxazole leads to toxicity and major histocompatibility complex-restricted antigen presentation","volume":"62","author":"Naisbitt","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.116.072041_bib21","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1124\/dmd.109.027797","article-title":"A zone classification system for risk assessment of idiosyncratic drug toxicity using daily dose and covalent binding","volume":"37","author":"Nakayama","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.116.072041_bib22","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/00008571-200007000-00001","article-title":"Evaluation of the genetic component of variability in CYP3A4 activity: a repeated drug administration method","volume":"10","author":"Ozdemir","year":"2000","journal-title":"Pharmacogenetics"},{"key":"10.1124\/dmd.116.072041_bib23","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cbi.2010.09.011","article-title":"Drug bioactivation and protein adduct formation in the pathogenesis of drug-induced toxicity","volume":"192","author":"Park","year":"2011","journal-title":"Chem Biol Interact"},{"key":"10.1124\/dmd.116.072041_bib24","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1124\/dmd.108.021725","article-title":"Covalent binding and tissue distribution\/retention assessment of drugs associated with idiosyncratic drug toxicity","volume":"36","author":"Takakusa","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.116.072041_bib25","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/S1473-3099(14)70780-7","article-title":"Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data","volume":"14","author":"Van Boeckel","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1124\/dmd.116.072041_bib26","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1021\/tx4003325","article-title":"Urinary biomarkers of trimethoprim bioactivation in vivo following therapeutic dosing in children","volume":"27","author":"van Haandel","year":"2014","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.116.072041_bib27","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0009-2797(81)90157-5","article-title":"A rapid and sensitive method for determination of covalent binding of benzo[a]pyrene to proteins","volume":"38","author":"Wallin","year":"1981","journal-title":"Chem Biol Interact"},{"key":"10.1124\/dmd.116.072041_bib28","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1081\/DMR-200028812","article-title":"Drug bioactivation, covalent binding to target proteins and toxicity relevance","volume":"37","author":"Zhou","year":"2005","journal-title":"Drug Metab Rev"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009095562409932X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009095562409932X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.116.072041","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T19:15:18Z","timestamp":1739906118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009095562409932X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S009095562409932X"],"URL":"https:\/\/doi.org\/10.1124\/dmd.116.072041","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bioactivation of Trimethoprim to Protein-Reactive Metabolites in Human Liver Microsomes","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.116.072041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}